Valley National Advisers’s Teladoc Health TDOC Stock Holding History

Valley National Advisers’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-351	Closed	-$3K	–	800
2024 Q3	$3K	Sell	351 -75	-18%	-$621	﹤0.01%	639
2024 Q2	$4K	Buy	426 +75	+21%	+$915	﹤0.01%	803
2024 Q1	$5K	Sell	351 -10	-3%	-$181	﹤0.01%	794
2023 Q4	$7K	Buy	361 +10	+3%	+$184	﹤0.01%	740
2023 Q3	$7K	Hold	351	–	–	﹤0.01%	666
2023 Q2	$9K	Hold	351	–	–	﹤0.01%	627
2023 Q1	$10K	Hold	351	–	–	﹤0.01%	596
2022 Q4	$8K	Buy	351 +112	+47%	+$3.02K	﹤0.01%	609
2022 Q3	$6K	Hold	239	–	–	﹤0.01%	662
2022 Q2	$10K	Hold	239	–	–	﹤0.01%	577
2022 Q1	$17K	Hold	239	–	–	﹤0.01%	539
2021 Q4	$22K	Hold	239	–	–	﹤0.01%	493
2021 Q3	$30K	Hold	239	–	–	0.01%	412
2021 Q2	$40K	Hold	239	–	–	0.01%	371
2021 Q1	$43K	Hold	239	–	–	0.01%	343
2020 Q4	$48K	Buy	+239	New	+$48.6K	0.01%	323

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MRCP

Maple Rock Capital Partners Toronto, Ontario, Canada $5.1B AUM 214.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Valley National Advisers's TDOC Position: Q4 2024 in Review

Valley National Advisers sold out of Teladoc Health (TDOC) in Q4 2024, closing a stake of 351 shares — an estimated $3K sold.

Valley National Advisers first reported a position in TDOC in Q4 2020 and held it in 16 quarters. The position peaked at $48K in Q4 2020. 381 funds tracked by Wall St. Rank hold TDOC as of Q4 2024.

Valley National Advisers reported no remaining Teladoc Health position as of Q4 2024 after selling out during the quarter.
Valley National Advisers sold 351 Teladoc Health shares in Q4 2024, an estimated $3K.
Valley National Advisers first reported a position in Teladoc Health in Q4 2020 and held it in 16 quarters.
Valley National Advisers's Teladoc Health position peaked at $48K in Q4 2020.
381 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2024.

Based on Valley National Advisers's 13F filing for Q4 2024, filed 24 Jan 2025.